This synergizes with CD8a+ T cell activation data (higher frequency of OX40+CD137+), enabling the vaccine to not only neutralize free viruses but also more efficiently eliminate virus-infected cells, establishing a more comprehensive immune defense system against viral infection. The gene discussed is TNFRSF9; the disease is viral infectious disease.